viewKanabo Group PLC

Kanabo raises funds as it snaps up stake in medical cannabis cultivator

The cannabis products maker has agreed to purchase £750,000 worth of shares in Hellenic Dynamics as part of the firm's planned IPO on the LSE

Kanabo Group PLC - Kanabo raises funds as it snaps up stake in medical cannabis cultivator

Kanabo Group PLC (LON:KNB) said it has raised £1mln in a share placing while also unveiling an investment in pre-IPO medical cannabis cultivator Hellenic Dynamics SA.

The developer of cannabis-derived products said it raised the funds through the placing of around 4.5mln shares at a price of 22p each, a 10% premium to its closing price last Friday, from new and existing investors.

READ: Medical cannabis grower Hellenic Dynamics plans to join London's budding sector

Meanwhile, the London-listed firm said it has purchased £750,000 worth of shares in Hellenic as part of a wider strategic partnership between the two companies. Helleniic's main aim is to cultivate, produce, and extract tetrahydrocannabinol (THC) dominant strains of dried medical cannabis flowers and flower extracts. 

Under the terms of a memorandum of understanding (MoU), Kanabo said it is envisaged that it will purchase up to 1,000 kilograms per year of EU GMP certified cannabis flowers from Hellenic with pre-defined THC or CBD contents for subsequent extraction of medical standard oils.

Kanabo will receive its shares as part of Hellenic’s planned initial public offering on the London Stock Exchange through a reverse takeover of an AIM-listed cash shell, adding that the prospective takeover is “well advanced” and further announcements are expected shortly.

"This agreement and investment in the business underscores the quality and scale of our specialist cultivation ambitions. We look forward to working closely with Kanabo and this deal highlights the demand and growth opportunity for Hellenic Dynamics in the European medical cannabis market," Hellenic’s vice president Davinder Rai said in a statement.

"The MoU with Hellenic Dynamics and the subsequent investment is part of Kanabo's strategy to quickly grow its core business whilst pursuing complementary, synergistic, acquisitions and investments in the medical cannabis space, leveraging our position as a quoted company. We welcome the enthusiastic support of investors for our approach," added Kanabo chief executive Avihu Tamir.

Quick facts: Kanabo Group PLC


Price: 18 GBX

Market Cap: £66.43 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


Kanabo Group begins delivering breakthrough medicinal cannabis vape...

Kanabo Group PLC (LON:KNB) chief executive Avihu Tamir joins Proactive after passing a significant commercial 'milestone' with the shipment of its first medicinal cannabis cartridges to the UK. They will be sold by the LYPHE Group's clinics and dispensaries to be used with Kanabo’s VapePod...

on 14/7/21

2 min read